January 7, 2011
First-Ever Guidelines for MRSA Treatment
(Ivanhoe Newswire) -- In an attempt to stop the MRSA superbug, the Infectious Disease Society of America (ISDA) released its first-ever guidelines for the treatment of MRSA, helping physicians manage the common antibiotic-resistant infection.
MRSA in the most common type of skin infection that sends people to the ER, and its invasive nature kills approximately 18,000 people a year.
Good hygiene is the best defense against MRSA, according to the Centers for Disease Control and Prevention (CDC), including keeping the hands clean, keeping cuts and scrapes clean and covered with a bandage, avoiding contact with other people's wounds, and avoiding sharing personal items such as towels or razors.
The IDSA guidelines address a variety of infections caused by MRSA that are commonly encountered by emergency room doctors, pediatricians, primary care physicians, hospitalists, infectious diseases specialists, pharmacists and other health care providers. Topics include: how to manage skin and soft tissue infections likely caused by community-associated MRSA; how to treat recurrent skin infections; recommendations regarding use of the intravenous antibiotic vancomycin and other antibiotics used for the treatment of MRSA; how to manage invasive infections, such as pneumonia, and infections in the bones, joints, blood or heart; and how to treat newborns who are infected with MRSA.
The voluntary guidelines are not meant to take the place of a doctor's judgment but rather to support the decision-making process, which must be individualized according to each patient's circumstances.
SOURCE: Clinical Infectious Diseases, published online January 5, 2010